Although only a few cases of insulinoma diagnosed following the use of GLP-1 or GIP/GLP-1 RAs have been reported [5-7], the potential for these agents to unmask or exacerbate insulinoma-related hypoglycemia warrants further investigation. This evidence concerns the gene GCG and pancreatic insulinoma.